GOV.UK
Drug misuse and dependency
Services
-
Misuse of drugs: annual statement of compliance
Annual statement of compliance with the requirements of the misuse of drugs legislation for year ending 31 December 2008.
-
ACMD open meeting 12 June 2014: registration form
Complete this form to attend the 'Diversion and Illicit Supply of Medicines Inquiry – Evidence Gathering' open meeting of the Advisory Council on the Misuse of Drugs.
Guidance and regulation
News and communications
Correspondence
Advice on the anticonvulsant drugs Pregabalin and Gabapentin
- Cannabis-derived medicinal products to be made available on prescription
- Home Office launches review into medical use of cannabis
- Prescribing of controlled drugs by therapeutic radiographers: further advice
- Drug misuse and dependency: government responses to ACMD reports
Research and statistics
- Opiate and crack cocaine use: prevalence estimates by local area
- People who inject drugs: HIV and viral hepatitis monitoring
- Drug misuse: findings from the 2017 to 2018 CSEW
- Drug and alcohol addiction, and obesity: effects on employment outcomes: claimants' views
- Reducing opioid-related deaths in the UK
Policy papers and consultations
- Cannabis-based medicines expert panel: terms of reference
- Drug strategy 2017
- Plant cannabinoids: ACMD report
- Diversion & illicit supply of medicines
Transparency and freedom of information releases
- Commissioning impact on drug treatment
- Psychoactive Substances Bill: evaluation review
- Drug strategy 2016: development review
- Methiopropamine: a review of the evidence of use and harm
- Methylphenidate base and methylphenidate hydrochloride importation, 2010 to 2012